Investigating The Effects Of Full-Spectrum Medicinal Cannabis Plant Extract 0.08% THC (NTI164) On Paediatric Acute-onset Neuropsychiatric Syndrome (PANS)

NCT06621888 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

PANS Pediatric Acute-Onset Neuropsychiatric Syndrome

Interventions

DRUG: NTI164

Sponsor

Fenix Innovation Group

Collaborators

[object Object]